{"transactions":[{"id":742964,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-11T01:49:38.000Z","date":"2026-06-08","kind":"exercise","planned":false,"acquired":false,"shares":1429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1429},"source":{"system":"sec-edgar","filing":"0001193125-26-266436","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526266436/ownership.xml","form_type":"4"}},{"id":742963,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:49:38.000Z","date":"2026-06-08","kind":"exercise","planned":false,"acquired":true,"shares":1429,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":11431,"source":{"system":"sec-edgar","filing":"0001193125-26-266436","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526266436/ownership.xml","form_type":"4"}},{"id":744449,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-09T21:16:19.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":1721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant."}],"balance_after":1721,"derivative":{"underlying":"Common Stock","underlying_shares":1721},"source":{"system":"sec-edgar","filing":"0001193125-26-264034","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526264034/ownership.xml","form_type":"4"}},{"id":955081,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-03T00:02:02.000Z","date":"2025-12-31","kind":"exercise","planned":true,"acquired":false,"shares":31346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":0,"derivative":{"exercise_price":4.95,"exercise_date":"2018-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":31346},"source":{"system":"sec-edgar","filing":"0001193125-26-001181","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526001181/ownership.xml","form_type":"4"}},{"id":955080,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-03T00:02:02.000Z","date":"2025-12-31","kind":"exercise","planned":true,"acquired":false,"shares":6231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":0,"derivative":{"exercise_price":8.02,"exercise_date":"2017-05-27","expiration_date":"2026-05-27","underlying":"Common Stock","underlying_shares":6231},"source":{"system":"sec-edgar","filing":"0001193125-26-001181","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526001181/ownership.xml","form_type":"4"}},{"id":955079,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-03T00:02:02.000Z","date":"2025-12-31","kind":"sale","planned":true,"acquired":false,"shares":31346,"price":165.18,"value":5177732.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $165.00 and $166.09."}],"balance_after":10002,"source":{"system":"sec-edgar","filing":"0001193125-26-001181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526001181/ownership.xml","form_type":"4"}},{"id":955078,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-03T00:02:02.000Z","date":"2025-12-31","kind":"exercise","planned":true,"acquired":true,"shares":31346,"price":4.95,"value":155162.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":41348,"source":{"system":"sec-edgar","filing":"0001193125-26-001181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526001181/ownership.xml","form_type":"4"}},{"id":955077,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-03T00:02:02.000Z","date":"2025-12-31","kind":"sale","planned":true,"acquired":false,"shares":6231,"price":165.18,"value":1029236.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $165.00 and $166.09."}],"balance_after":10002,"source":{"system":"sec-edgar","filing":"0001193125-26-001181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526001181/ownership.xml","form_type":"4"}},{"id":955076,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-03T00:02:02.000Z","date":"2025-12-31","kind":"exercise","planned":true,"acquired":true,"shares":6231,"price":8.02,"value":49972.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":16233,"source":{"system":"sec-edgar","filing":"0001193125-26-001181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526001181/ownership.xml","form_type":"4"}},{"id":1046749,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-05T23:43:07.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":false,"shares":9127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options, which would occur within the next two months."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed."}],"balance_after":0,"derivative":{"exercise_price":9,"exercise_date":"2016-11-19","expiration_date":"2025-11-19","underlying":"Common Stock","underlying_shares":9127},"source":{"system":"sec-edgar","filing":"0000950170-25-113311","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000095017025113311/ownership.xml","form_type":"4"}},{"id":1046748,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T23:43:07.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":9127,"price":125.07,"value":1141513.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $125.00 and $125.22."}],"balance_after":10002,"source":{"system":"sec-edgar","filing":"0000950170-25-113311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000095017025113311/ownership.xml","form_type":"4"}},{"id":1046747,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T23:43:07.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":true,"shares":9127,"price":9,"value":82143.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options, which would occur within the next two months."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed."}],"balance_after":19129,"source":{"system":"sec-edgar","filing":"0000950170-25-113311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000095017025113311/ownership.xml","form_type":"4"}},{"id":1116175,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-10T23:00:06.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":1429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on the one-year anniversary of the date of grant, June 6, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on the one-year anniversary of the date of grant, June 6, 2026."}],"balance_after":1429,"derivative":{"underlying":"Common Stock","underlying_shares":1429},"source":{"system":"sec-edgar","filing":"0000950170-25-084555","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000095017025084555/ownership.xml","form_type":"4"}},{"id":1116174,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-10T23:00:06.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":3166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on the one-year anniversary of the date of grant, June 6, 2026."}],"balance_after":3166,"derivative":{"exercise_price":111.91,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":3166},"source":{"system":"sec-edgar","filing":"0000950170-25-084555","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000095017025084555/ownership.xml","form_type":"4"}},{"id":1245720,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-26T00:59:08.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":1494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 1,494 options elected to be received in lieu of cash compensation earned in 2024. All of such options are immediately exercisable."}],"balance_after":1494,"derivative":{"exercise_price":137.75,"exercise_date":"2025-02-21","expiration_date":"2035-02-20","underlying":"Common Stock","underlying_shares":1494},"source":{"system":"sec-edgar","filing":"0000950170-25-027076","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000095017025027076/ownership.xml","form_type":"4"}},{"id":1409610,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-11T23:00:37.000Z","date":"2024-09-11","kind":"exercise","planned":true,"acquired":false,"shares":11016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options, which would occur later this month."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":0,"derivative":{"exercise_price":3.67,"exercise_date":"2015-09-16","expiration_date":"2024-09-16","underlying":"Common Stock","underlying_shares":11016},"source":{"system":"sec-edgar","filing":"0000950170-24-105616","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000095017024105616/ownership.xml","form_type":"4"}},{"id":1409609,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T23:00:37.000Z","date":"2024-09-11","kind":"sale","planned":true,"acquired":false,"shares":11016,"price":91.31,"value":1005870.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $90.25 and $92.90."}],"balance_after":10002,"source":{"system":"sec-edgar","filing":"0000950170-24-105616","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000095017024105616/ownership.xml","form_type":"4"}},{"id":1409608,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T23:00:37.000Z","date":"2024-09-11","kind":"exercise","planned":true,"acquired":true,"shares":11016,"price":3.67,"value":40428.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options, which would occur later this month."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":21018,"source":{"system":"sec-edgar","filing":"0000950170-24-105616","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000095017024105616/ownership.xml","form_type":"4"}},{"id":1483255,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T20:30:57.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":5799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on the one-year anniversary of the date of grant, June 7, 2025."}],"balance_after":5799,"derivative":{"exercise_price":73.9,"exercise_date":"2025-06-07","expiration_date":"2034-06-07","underlying":"Common Stock","underlying_shares":5799},"source":{"system":"sec-edgar","filing":"0000950170-24-071961","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000095017024071961/ownership.xml","form_type":"4"}},{"id":1609782,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-29T23:34:13.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":1519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 1,519 options elected to be received in lieu of cash compensation earned in 2023. All of such options are immediately exercisable."}],"balance_after":1519,"derivative":{"exercise_price":84,"exercise_date":"2024-02-27","expiration_date":"2034-02-26","underlying":"Common Stock","underlying_shares":1519},"source":{"system":"sec-edgar","filing":"0000950170-24-023374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000095017024023374/ownership.xml","form_type":"4"}},{"id":1865024,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-06T22:22:44.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":5681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, June 2, 2024."}],"balance_after":5681,"derivative":{"exercise_price":74.12,"exercise_date":"2024-06-02","expiration_date":"2033-06-02","underlying":"Common Stock","underlying_shares":5681},"source":{"system":"sec-edgar","filing":"0001209191-23-034850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919123034850/doc4.xml","form_type":"4"}},{"id":1968728,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T23:12:45.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":2224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 2,224 options elected to be received in lieu of cash compensation earned in 2022. All of such options are immediately exercisable."}],"balance_after":2224,"derivative":{"exercise_price":65.32,"exercise_date":"2023-03-02","expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":2224},"source":{"system":"sec-edgar","filing":"0001209191-23-016453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919123016453/doc4.xml","form_type":"4"}},{"id":2240022,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T20:08:05.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":16976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, June 3, 2023."}],"balance_after":16976,"derivative":{"exercise_price":25.53,"exercise_date":"2023-06-03","expiration_date":"2032-06-03","underlying":"Common Stock","underlying_shares":16976},"source":{"system":"sec-edgar","filing":"0001209191-22-034826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919122034826/doc4.xml","form_type":"4"}},{"id":2344188,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-08T22:00:15.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":2337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 2,337 options elected to be received in lieu of cash compensation earned in 2021. All of such options are immediately exercisable."}],"balance_after":2337,"derivative":{"exercise_price":29.91,"exercise_date":"2022-03-04","expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":2337},"source":{"system":"sec-edgar","filing":"0001209191-22-017153","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919122017153/doc4.xml","form_type":"4"}},{"id":2502481,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T12:30:28.000Z","date":"2021-11-17","kind":"purchase","acquired":true,"shares":100,"price":34.4,"value":3440.0,"ownership":{"direct":false,"nature":"Custodial account for child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001209191-21-065696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919121065696/doc4.xml","form_type":"4"}},{"id":2502480,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T12:30:28.000Z","date":"2021-11-17","kind":"purchase","acquired":true,"shares":100,"price":34.45,"value":3445.0,"ownership":{"direct":false,"nature":"Custodial account for child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001209191-21-065696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919121065696/doc4.xml","form_type":"4"}},{"id":2502479,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T12:30:28.000Z","date":"2021-11-17","kind":"purchase","acquired":true,"shares":100,"price":34.395,"value":3439.5,"ownership":{"direct":false,"nature":"Custodial account for child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001209191-21-065696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919121065696/doc4.xml","form_type":"4"}},{"id":2502478,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T12:30:28.000Z","date":"2021-11-17","kind":"purchase","acquired":true,"shares":3000,"price":34.5324,"value":103597.2,"ownership":{"direct":true},"balance_after":10002,"source":{"system":"sec-edgar","filing":"0001209191-21-065696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919121065696/doc4.xml","form_type":"4"}},{"id":2677310,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-08T20:52:53.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":7325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, June 4, 2022."}],"balance_after":7325,"derivative":{"exercise_price":61.32,"exercise_date":"2022-06-04","expiration_date":"2031-06-04","underlying":"Common Stock","underlying_shares":7325},"source":{"system":"sec-edgar","filing":"0001209191-21-038955","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919121038955/doc4.xml","form_type":"4"}},{"id":2799648,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-10T02:47:19.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":1241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 1,241 options elected to be received in lieu of cash compensation earned in 2020. All of such options are immediately exercisable."}],"balance_after":1241,"derivative":{"exercise_price":65.02,"exercise_date":"2021-03-05","expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":1241},"source":{"system":"sec-edgar","filing":"0000899243-21-010809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000089924321010809/doc4.xml","form_type":"4"}},{"id":2913534,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-07T23:08:10.000Z","date":"2021-01-05","kind":"grant","acquired":true,"shares":8227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person has elected to receive his 2021 retainer compensation in restricted stock, rather than cash. Subject to the Reporting Person continuing to be a \"Service Provider\" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date, the shares shall vest as follows: 25% of the shares subject to the restricted stock award shall vest quarterly on the fifth of the month immediately following the end of the quarter corresponding with the date of grant (i.e. April 5, 2021, July 5, 2021, October 5, 2021, and January 5, 2022), such that the shares shall be fully vested on January 5, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 16, 2020, the common stock of the company reverse-split 25-for-1, resulting in the reporting persons ownership being reduced by 132,562."}],"balance_after":13750,"source":{"system":"sec-edgar","filing":"0001209191-21-002576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919121002576/doc4.xml","form_type":"4"}},{"id":3007085,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-14T21:54:26.000Z","date":"2020-10-12","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported shares represents a grant of restricted stock awards (the \"RSAs\") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) October 12, 2021, or (ii) the day prior to the date of the Annual Meeting next following October 12, 2020, subject to the reporting person's continued service."}],"balance_after":138085,"source":{"system":"sec-edgar","filing":"0001209191-20-054820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919120054820/doc4.xml","form_type":"4"}},{"id":3120151,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-05T22:42:12.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, June 5, 2021."}],"balance_after":13000,"derivative":{"exercise_price":77.38,"exercise_date":"2021-06-05","expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001179110-20-007058","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000117911020007058/edgar.xml","form_type":"4"}},{"id":3200496,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-20T01:17:14.000Z","date":"2020-03-17","kind":"grant","acquired":true,"shares":3789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 3,789 options elected to be received in lieu of cash compensation earned in 2019. All of such options are immediately exercisable."}],"balance_after":3789,"derivative":{"exercise_price":45.14,"exercise_date":"2020-03-17","expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":3789},"source":{"system":"sec-edgar","filing":"0001179110-20-004006","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000117911020004006/edgar.xml","form_type":"4"}},{"id":3315167,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-08T22:44:22.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":49576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person has elected to receive his 2020 retainer compensation in stock option grants, rather than cash. Subject to the Reporting Person continuing to be a \"Service Provider\" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date, the shares shall vest as follows: 25% of the shares subject to the option shall vest quarterly on the fifth of the month immediately following the end of the quarter corresponding with the date of grant (i.e. April 5, 2020, July 5, 2020, October 5, 2020, and January 5, 2021), such that the shares shall be fully vested on January 5, 2021."}],"balance_after":49576,"derivative":{"exercise_price":1.18,"expiration_date":"2030-01-06","underlying":"Common Stock","underlying_shares":49576},"source":{"system":"sec-edgar","filing":"0001209191-20-002586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919120002586/doc4.xml","form_type":"4"}},{"id":3495565,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-10T22:21:15.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, June 7, 2020."}],"balance_after":13000,"derivative":{"exercise_price":22.03,"exercise_date":"2020-06-07","expiration_date":"2029-06-07","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001104659-19-034643","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000110465919034643/a4.xml","form_type":"4"}},{"id":3497022,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-07T21:55:04.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":29850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported shares represents a grant of restricted stock units (the \"RSUs\") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSUs will vest on the earlier of (i) June 6, 2020, or (ii) the day prior to the date of the Annual Meeting next following June 6, 2019, subject to the reporting person's continued service."}],"balance_after":38085,"source":{"system":"sec-edgar","filing":"0001209191-19-035637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919119035637/doc4.xml","form_type":"4"}},{"id":3511574,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-24T11:19:44.000Z","date":"2019-05-23","kind":"purchase","acquired":true,"shares":3500,"price":22.33,"value":78155.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased by the reporting person in multiple transactions at prices ranging from $22.30 to $22.35, inclusive. The reporting person undertakes to provide to Axsome Therapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":7002,"source":{"system":"sec-edgar","filing":"0001179110-19-006616","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000117911019006616/edgar.xml","form_type":"4"}},{"id":3582808,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-21T20:07:43.000Z","date":"2019-03-19","kind":"grant","acquired":true,"shares":29387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 29,387 options elected to be received in lieu of cash compensation earned in 2018. All of such options are immediately exercisable."}],"balance_after":29387,"derivative":{"exercise_price":12.95,"exercise_date":"2019-03-19","expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":29387},"source":{"system":"sec-edgar","filing":"0001104659-19-016572","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000110465919016572/a4.xml","form_type":"4"}},{"id":3795900,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-05T22:08:23.000Z","date":"2018-10-04","kind":"grant","acquired":true,"shares":8235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported shares are represented by restricted stock units (\"RSUs\"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. 1/3rd of the RSUs shall vest annually beginning on October 4, 2019 such that the RSUs will be fully vested on October 4, 2021, subject to the reporting person's continued service."}],"balance_after":8235,"source":{"system":"sec-edgar","filing":"0001209191-18-054435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000120919118054435/doc4.xml","form_type":"4"}},{"id":3904988,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-06-06T00:21:11.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, June 1, 2019."}],"balance_after":13000,"derivative":{"exercise_price":3.45,"exercise_date":"2019-06-01","expiration_date":"2028-06-01","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001104659-18-038399","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000110465918038399/a4.xml","form_type":"4"}},{"id":3968354,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-05T14:05:18.000Z","date":"2018-03-12","kind":"grant","acquired":true,"shares":32602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 32,602 options elected to be received in lieu of cash compensation earned in 2017.  All of such options are immediately exercisable."}],"balance_after":32602,"derivative":{"exercise_price":2.85,"exercise_date":"2018-03-12","expiration_date":"2028-03-11","underlying":"Common Stock","underlying_shares":32602},"source":{"system":"sec-edgar","filing":"0001104659-18-022601","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000110465918022601/a4.xml","form_type":"4"}},{"id":4379622,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-17T20:55:38.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the one-year anniversary of the date of grant, March 15, 2018."}],"balance_after":11000,"derivative":{"exercise_price":4.95,"exercise_date":"2018-03-15","expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-17-017639","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000110465917017639/a4.xml","form_type":"4"}},{"id":4379621,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-17T20:55:38.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":31346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 11,000 options granted as compensation for service during 2016 and 20,346 options elected to be received in lieu of cash compensation earned in 2016.  All of such options are immediately exercisable."}],"balance_after":31346,"derivative":{"exercise_price":4.95,"exercise_date":"2017-03-15","expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":31346},"source":{"system":"sec-edgar","filing":"0001104659-17-017639","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000110465917017639/a4.xml","form_type":"4"}}]}